StevenChmuraMDPhD
Radiation Oncology • Chicago, ILBreast Cancer, Central Nervous System Cancer
Associate Professor of Radiation and Cellular Oncology, University of Chicago Medicine
Dr. Chmura is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-834-7168
Education & Training
University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2000 - 2004
Louis A Weiss Memorial HospitalInternship, Internal Medicine, 1999 - 2000
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1999
Certifications & Licensure
IL State Medical License 1999 - 2026
IN State Medical License 2024 - 2025- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- 131-I-TM-601 Study in Adults With Solid Tumors Start of enrollment: 2006 Aug 01
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
- Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer Start of enrollment: 2005 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 408 citationsSafety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors.Jason J. Luke, Jeffrey Lemons, Theodore Karrison, Sean P. Pitroda, J.M. Melotek
Journal of Clinical Oncology. 2018-02-13 - 64 citationsIntensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques.Michael T. Milano, Michael C. Garofalo, Steven J. Chmura, K. Farrey, Carla Rash
The British Journal of Radiology. 2006-06-01 - 307 citationsImproved survival time trends for glioblastoma using the SEER 17 population-based registriesMatthew Koshy, John L. Villano, Therese A. Dolecek, Andrew Howard, Usama Mahmood
Journal of Neuro-Oncology. 2012-03-01
Journal Articles
- Structured Radiation Oncology Clerkship Curricula: Evaluating the Effect on Residency Applicant Knowledge of Radiation OncologyGregory Kauffmann, Steven J Chmura, Journal of the American College of Radiology
- Classification for Long-Term Survival in Oligometastatic Patients Treated with Ablative Radiotherapy: A Multi-Institutional Pooled AnalysisJulian C Hong, A William Blackstock, Joseph K Salama, Paul Okunieff, Michael T Milano, James J Urbanic, Ralph R Weichselbaum, Johnny Kao, Max W Sung, Steven J Chmura, PLoS One
Lectures
- NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic b...2019 ASCO Annual Meeting - 6/1/2019
- Chicago Breast Reconstruction SymposiumUniversity of Chicago, Chicago, Illinois - 9/20/2013
Other
- Treatment of locally recurrent head and neck cancerChmura SJ, Haraf DJ, Milano MT
http://www.uptodate.com/contents/treatment-of-locally-recurrent-head-and-neck-cancer
UpToDate, Wolters Kluwer Health - 2012-08-29
Authored Content
- Structured Radiation Oncology Clerkship Curricula: Evaluating the Effect on Residency Applicant Knowledge of Radiation OncologyJuly 2018
Press Mentions
The AACR Annual Meeting Is Virtual for a Second Consecutive YearApril 26th, 2021- Study Finds Stereotactic Body Radiotherapy Is Safe for Treating Patients with Multiple MetastasesApril 21st, 2021
SBRT Found to Be Safe Treatment for Patients with Multiple MetastasesOctober 24th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
